CORRESP 1 filename1.htm

 

IDERA PHARMACEUTICALS, INC.
167 Sidney Street
Cambridge, Massachusetts 02139

 

September 7, 2017

 

By EDGAR Submission

 

Securities and Exchange Commission

Division of Corporation Finance

100 F Street, N.E.

Washington, D.C.  20549

 

Re:              Idera Pharmaceuticals, Inc.
Registration Statement on Form S-3
File No. 333-219851
Request for Acceleration

 

Ladies and Gentlemen:

 

Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Idera Pharmaceuticals, Inc. hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-219851) so that it may become effective at 4:00 p.m., Eastern time, on September 8, 2017, or as soon thereafter as practicable.

 

[The remainder of this page is intentionally left blank.]

 


 

 

Very truly yours,

 

 

 

IDERA PHARMACEUTICALS, INC.

 

 

 

 

 

/s/ Louis J. Arcudi, III

 

Louis J. Arcudi, III

 

Chief Financial Officer and Treasurer